AI
LMAT icon

Analytic Investors’s LeMaitre Vascular LMAT Stock Holding History

Analytic Investors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.03M Sell
51,808
-40,687
-44% -$711K 0.01% 366
2016
Q2 		$1.32M Buy
92,495
+12,570
+16% +$192K 0.02% 339
2016
Q1 		$1.24M Buy
79,925
+13,066
+20% +$187K 0.02% 374
2015
Q4 		$1.15M Sell
66,859
-1,833
-3% -$26.5K 0.01% 378
2015
Q3 		$837K Buy
+68,692
New +$881K 0.01% 392

Other funds holding LMAT

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Analytic Investors's LMAT Position: Q3 2016 in Review

Analytic Investors reduced its LeMaitre Vascular (LMAT) stake by 44% in Q3 2016, selling an estimated $711K and leaving 51,808 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #366.

Analytic Investors first reported a position in LMAT in Q3 2015 and has held it in 5 quarters since. The position peaked at $1.32M in Q2 2016. 111 funds tracked by Wall St. Rank hold LMAT as of Q3 2016.

  • Analytic Investors held 51,808 shares of LeMaitre Vascular worth $1.03M as of Q3 2016.
  • Analytic Investors sold 40,687 LeMaitre Vascular shares in Q3 2016, an estimated $711K.
  • LeMaitre Vascular made up 0.01% of Analytic Investors's portfolio in Q3 2016, its #366 holding.
  • Analytic Investors first reported a position in LeMaitre Vascular in Q3 2015 and has held it in 5 quarters since.
  • Analytic Investors's LeMaitre Vascular position peaked at $1.32M in Q2 2016.
  • 111 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.